Dimensioni, segmenti e analisi del mercato terapeutico dei piccoli RNA interferenti (siRNA) entro il 2025-2031
Small Interfering RNA (siRNA) Therapeutics Market Report Analysis
Small Interfering RNA (siRNA) Therapeutics Market
-
CAGR (2023 - 2031)XX% -
Market Size 2023
US$ XX million -
Market Size 2031
US$ XX Million
Report Coverage
- Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Key future trends
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- Industry landscape and competition analysis & recent developments
- Detailed company profiles
- Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
Key Players
- Horizon Discovery
- GlaxoSmithKline
- Sirna Therapeutics, Inc.
- Alnylam Pharmaceuticals
- Sanofi Genzyme
- Olix Pharmaceuticals
- Silence Therapeutics AG
- Calando Pharmaceuticals
- Arbutus Biopharma Corp
Regional Overview
- Nord America
- Europa
- Asia-Pacifico
- America centrale e meridionale
- Medio Oriente e Africa
Market Segmentation
By Indicazione
- Oncologia
- Malattie cardiovascolari
- Patologie respiratorie
- Patologie neurodegenerative
- Malattie infettive
- Altro
By Tipi
- terapia sistemica basata su liposomi
- terapia sistemica basata su nanoparticelle
- altro
By Utente finale
- laboratorio diagnostico
- laboratori di ricerca e accademici
By Geografia
- America del Nord
- Europa
- Asia-Pacifico
- America centrale e meridionale
Get Free Sample For